Avelumab plus axitinib for translocation renal cell carcinoma: A case series and literature review

Avelumab plus axitinib for translocation renal cell carcinoma: A case series and literature review

Introduction Patients with translocation renal cell carcinoma (tRCC) have a poor prognosis without standardized treatment. Case presentation The first case was of a 72‐year‐old woman who underwent robot‐assisted partial nephrectomy for a left renal tumor and was pathologically diagnosed with tRCC. R...

Full description

Bibliographic Details
Main Authors: Kenta Takahashi, Renpei Kato, Daiki Ikarashi, Tomohiko Matsuura, Shigekatsu Maekawa, Mitsugu Kanehira, Ryo Takata, Jun Sugimura, Takaya Abe, Wataru Obara
Format: Article
Language:English
Published: Wiley 2024-03-01
Series:IJU Case Reports
Subjects:
avelumab
axitinib
immune checkpoint inhibitors
renal cell carcinoma
translocation renal cell carcinoma
Online Access:https://doi.org/10.1002/iju5.12685

Internet

https://doi.org/10.1002/iju5.12685

Similar Items